Allicin ameliorates doxorubicin-induced cardiotoxicity in rats via suppression of oxidative stress, inflammation and apoptosis

被引:0
作者
Mohamed M. Abdel-Daim
Omnia E. kilany
Hesham A. Khalifa
Amal A. M. Ahmed
机构
[1] Suez Canal University,Department of Pharmacology, Faculty of Veterinary Medicine
[2] Suez Canal University,Department of Clinical Pathology, Faculty of Veterinary Medicine
[3] Zagazig University,Department of Pharmacology, Faculty of Veterinary Medicine
[4] Suez Canal University,Cytology and Histology Department, Faculty of Veterinary Medicine
来源
Cancer Chemotherapy and Pharmacology | 2017年 / 80卷
关键词
Adriamycin; Heart; Cardiotoxicity; Oxidative damage; Inflammation; Apoptosis; Garlic; Antioxidant; Anti-inflammatory;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:745 / 753
页数:8
相关论文
共 50 条
  • [41] Heat Shock Protein 22 Attenuates Doxorubicin-Induced Cardiotoxicity via Regulating Inflammation and Apoptosis
    Lan, Yin
    Wang, Yi
    Huang, Kun
    Zeng, Qiutang
    FRONTIERS IN PHARMACOLOGY, 2020, 11
  • [42] PPARα Ameliorates Doxorubicin-Induced Cardiotoxicity by Reducing Mitochondria-Dependent Apoptosis via Regulating MEOX1
    Wang, Wei
    Fang, Qin
    Zhang, Zhihao
    Wang, Daowen
    Wu, Lujin
    Wang, Yan
    FRONTIERS IN PHARMACOLOGY, 2020, 11
  • [43] Potential Protective Effect of Orlistat: A Formulation of Nanocrystals Targeting Inflammation, Oxidative Stress, and Apoptosis in an Experimental Model of Doxorubicin-Induced Cardiotoxicity
    Alsunbul, Maha
    El-Masry, Thanaa A.
    El Zahaby, Enas I.
    Gaballa, Mohamed M. S.
    El-Nagar, Maysa M. F.
    PHARMACEUTICS, 2024, 16 (11)
  • [44] Fluvastatin alleviates doxorubicin-induced cardiac and renal toxicity in rats via regulation of oxidative stress, inflammation, and apoptosis associated genes expressions
    Kuscu, Gokce Ceren
    Gurel, Cevik
    Buhur, Aylin
    Yavasoglu, Nefise Ulku Karabay
    Kose, Timur
    Yavasoglu, Altug
    Oltulu, Fatih
    DRUG AND CHEMICAL TOXICOLOGY, 2023, 46 (02) : 400 - 411
  • [45] Cardiorenal Protective Effect of Costunolide against Doxorubicin-Induced Toxicity in Rats by Modulating Oxidative Stress, Inflammation and Apoptosis
    Xing, Wen
    Wen, Chaoling
    Wang, Deguo
    Shao, Hui
    Liu, Chunhong
    He, Chunling
    Olatunji, Opeyemi Joshua
    MOLECULES, 2022, 27 (07):
  • [46] Sulfiredoxin 1 ameliorates doxorubicin-induced cardiotoxicity by suppressing oxidative stress and inflammation via the Sirt1/ NLRP3 pathway
    Zhang, Zhaoxia
    Du, Tingsha
    Wu, Nan
    Yang, Shuwen
    Wang, Jian
    Peng, Jianye
    Jia, Zhenyu
    Dai, Jiating
    Du, Xianfeng
    Feng, Mingjun
    Chu, Huimin
    Shen, Caijie
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2024, 141
  • [47] Protection by pitavastatin from doxorubicin-induced acute cardiotoxicity through suppression of oxidative stress
    Xin, Yan-fei
    Han, Bin
    Zhou, Guo-liang
    You, Zhen-qiang
    Gu, Li-qiang
    Gao, Hai-yan
    Zhang, Sheng
    Yu, Jian
    Xuan, Yao-xian
    ACTA PHARMACOLOGICA SINICA, 2013, 34 : 74 - 74
  • [48] Chrysanthemum morifolium Extract Ameliorates Doxorubicin-Induced Cardiotoxicity by Decreasing Apoptosis
    Ono, Masaya
    Sunagawa, Yoichi
    Mochizuki, Saho
    Katagiri, Takahiro
    Takai, Hidemichi
    Iwashimizu, Sonoka
    Inai, Kyoko
    Funamoto, Masafumi
    Shimizu, Kana
    Shimizu, Satoshi
    Katanasaka, Yasufumi
    Komiyama, Maki
    Hawke, Philip
    Hara, Hideo
    Arakawa, Yoshiki
    Mori, Kiyoshi
    Asai, Akira
    Hasegawa, Koji
    Morimoto, Tatsuya
    CANCERS, 2022, 14 (03)
  • [49] Mitigation of doxorubicin-induced cardiotoxicity by dichloroacetate: potential roles of restoration of PGC-1α/SIRT3 signaling and suppression of oxidative stress and apoptosis
    Saleh, M. F.
    Elsayad, M. E.
    Goda, A. E.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2021, 25 (21) : 6573 - 6584
  • [50] C-phycocyanin ameliorates doxorubicin-induced oxidative stress and apoptosis in adult rat cardiomyocytes
    Khan, M
    Varadharaj, S
    Shobha, JC
    Naidu, MU
    Parinandi, NL
    Kutala, VK
    Kuppusamy, P
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2006, 47 (01) : 9 - 20